Search

Search Constraints

You searched for: Author/Creator Zang, Ruochuan

Search Results

1. Combined detection of aneuploid circulating tumor‐derived endothelial cells and circulating tumor cells may improve diagnosis of early stage non‐small‐cell lung cancer. Issue 3 (13th July 2020)

3. Enhancement of diagnostic performance in lung cancers by combining CEA and CA125 with autoantibodies detection. (3rd October 2019)

4. Interferon-inducible lncRNA IRF1-AS represses esophageal squamous cell carcinoma by promoting interferon response. (10th September 2019)

7. The average copy number variation (CNVA) of chromosome fragments is a potential surrogate for tumor mutational burden in predicting responses to immunotherapy in non‐small‐cell lung cancer. Issue 1 (4th January 2021)

8. The superior efficacy of anti-PD-1/PD-L1 immunotherapy in KRAS-mutant non-small cell lung cancer that correlates with an inflammatory phenotype and increased immunogenicity. (1st February 2020)

9. Tumor microenvironment characterization identifies two lung adenocarcinoma subtypes with specific immune and metabolic state. Issue 6 (17th April 2020)

10. Utility of isocitrate dehydrogenase 1 as a serum protein biomarker for the early detection of non‐small‐cell lung cancer: A multicenter in vitro diagnostic clinical trial. Issue 5 (5th May 2020)